Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

Drug‐eluting stents have reduced the frequency of in‐stent restenosis. However, most of the
results have been derived from simple lesions in noncomplex patients. In preclinical normal …

In summary, the committee concludes that elective stenting in selected patient subsets
enhances the result of percutaneous coronary interventional procedures. In these subsets …

In-stent restenosis is the major drawback of percutaneous coronary interventions, occurring
in 10–40% of the patients. Recently, new stents have emerged which are loaded with anti …

This is a comment on" Stent thrombosis in randomized clinical trials of drug-eluting stents." N
Engl J Med. 2007 Mar 8; 356 (10): 1020-9. This is a comment on" Long-term outcomes with …

At present, 90 to 95 percent of percutaneous coronary interventions involve the implantation
of a stent, often a drug-eluting stent, though most published data originated in the era of bare …

Coronary stents have revolutionized the treatment of coronary artery disease. Compared
with balloon angioplasty, bare-metal stents (BMSs) effectively prevented abrupt vessel …

Despite all the benefits of drug-eluting stents (DES), concerns have been raised over their
long-term safety, with particular reference to stent thrombosis. In an effort to address these …

The subspecialty of interventional cardiology has made significant progress in the
management of coronary artery disease over the past three decades with the development …

Percutaneous coronary intervention has become a standard-of-care procedure in patients
with acute and chronic coronary syndromes, in which coronary stent technology is …